News
VANCOUVER, BC / ACCESS Newswire / June 27, 2025 / Onco-Innovations Limited(CBOE CA:ONCO)(Frankfurt:W1H,WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce that its wholly-owned subsidiary, I ...
VANCOUVER, BC / ACCESS Newswire / June 27, 2025 / Onco-Innovations Limited(CBOE CA:ONCO)(Frankfurt:W1H,WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce that its wholly-owned subsidiary, ...
In an extraordinary demonstration of surgical expertise, doctors at Jehangir Hospital, Pune, successfully removed an ...
With low immunity due to cancer or its treatments like chemotherapy and radiation, even a small infection during the monsoon ...
Non-profit organization I Want To Share Foundation (IWTS) once again hosted the “CAn Beat It” ceremony to officially honor the resilience of 115 pediatric cancer survivors who successfully completed ...
Glenmark Pharmaceuticals has launched the lung cancer drug Tevimbra in India after approval by the Central Drugs Standard Control Organisation. Developed by global oncology leader BeiGene, now BeOne ...
The patient recovered well and was discharged 10 days later, with her weight dropping from 116 kg to 96 kg post-surgery.
8d
TipRanks on MSNOnco-Innovations Advances Real-World Applicability of Lung Cancer TrialsOnco-Innovations Limited announced a significant study by the co-founders of its subsidiary, Inka Health Corp., which advances the real-world applicability of lung cancer clinical ...
VANCOUVER, BC / ACCESS Newswire / June 20, 2025 / Onco-Innovations Limited(CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H,WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce that the Co-Founders of ...
VANCOUVER, BC / ACCESS Newswire / June 20, 2025 / Onco-Innovations Limited(CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H,WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce that the Co-Founders of ...
Meanwhile, Nova One Advisor projects the global oncology drug market will climb to US$366.24 billion by 2034, expanding at a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results